Jonathan M. Coutinho

Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I

Jenelle M. Timmins, Elena Boudyguina, Kimberly D. Kluckman et al. · Journal of Clinical Investigation · 2005 · 445 citations

Targeted inactivation of hepatic Abca1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of apoA-I

Jenelle M. Timmins, Ji‐Young Lee, Elena Boudyguina et al. · Journal of Clinical Investigation · 2005 · 419 citations · Full text

Endovascular treatment versus no endovascular treatment after 6–24 h in patients with ischaemic stroke and collateral flow on CT angiography (MR CLEAN-LATE) in the Netherlands: a multicentre, open-label, blinded-endpoint, randomised, controlled, phase 3 trial

Susanne G. H. Olthuis, F.A.V. Pirson, Florentina M.E. Pinckaers et al. · The Lancet · 2023 · 211 citations · Full text

Endovascular Technique, Cerebrovascular Disease, Thrombosis +17

Andexanet for Factor Xa Inhibitor–Associated Acute Intracerebral Hemorrhage

Stuart J. Connolly, Mukul Sharma, Alexander T. Cohen et al. · New England Journal of Medicine · 2024 · 200 citations · Full text

Factor XIa inhibition with asundexian after acute non-cardioembolic ischaemic stroke (PACIFIC-Stroke): an international, randomised, double-blind, placebo-controlled, phase 2b trial

Ashkan Shoamanesh, Hardi Mundl, Eric E. Smith et al. · The Lancet · 2022 · 181 citations · Full text

Thrombosis, Cardiovascular Disease, Ischemic Stroke +14